SCHEMBL6015583

SCHEMBL6015583

Clc1cccc(-c2nnc(SCc3ccccn3)[nH]2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.45
CYP2E1 P05181 6/20 0.45
CYP2C8 P10632 6/20 0.45
CYP2D6 P10635 6/20 0.45
CYP2C9 P11712 6/20 0.45
CYP2B6 P20813 6/20 0.45
CYP2C19 P33261 6/20 0.45
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
MAPT P10636 2/20 0.44
HRH1 P35367 1/20 0.43
CYP3A4 P08684 5/20 0.43
GRIN1 Q05586 1/20 0.42
GRIN2B Q13224 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6015592 0.86 KDM4E (0.52) CYP1A2CYP2E1CYP2C8CYP2D6CYP2C9
SCHEMBL6015612 0.85 CYP1A2 (0.54) CYP1A2CYP2E1CYP2C8CYP2D6CYP2C9
SCHEMBL6404980 0.82 L3MBTL1 (0.52) RAB9AHRH1L3MBTL1MEN1KMT2A
SCHEMBL6015584 0.79 CYP1A2 (0.48) CYP1A2CYP2E1CYP2C8CYP2D6CYP2C9
SCHEMBL6015598 0.79 CYP1A2 (0.54) CYP1A2CYP2E1CYP2C8CYP2D6CYP2C9
SCHEMBL6015607 0.78 CYP1A2 (0.45) CYP1A2CYP2E1CYP2C8CYP2D6CYP2C9
SCHEMBL14777923 0.77 KDM4E (0.47) CYP1A2CYP2E1CYP2C8CYP2D6CYP2C9
SCHEMBL6015593 0.77 DYRK1A (0.46) CYP1A2CYP2E1CYP2C8CYP2D6CYP2C9
SCHEMBL6015581 0.77 RAB9A (0.58) CYP1A2CYP2E1CYP2C8CYP2D6CYP2C9
SCHEMBL6015609 0.76 RAB9A (0.57) CYP1A2CYP2E1CYP2C8CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012054526-A2 CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES ELCELYX THERAPEUTICS, INC. (US) 2012-04-26 WO disclosed